NOETIK is a frontier therapeutics company harnessing AI to deeply understand human biology and redefine clinical outcomes in oncology. The role involves building and driving Noetik’s oncology pipeline strategy, with responsibilities including asset scouting, valuation, and portfolio governance.
Responsibilities:
- Source and advance in-licensing and co-development opportunities (Ph1b–Ph3)
- Build asset-level valuation models that translate platform outputs into defensible economics
- Develop prioritization framework for pipeline opportunities to align internal decisions, partner engagement and negotiations, and investor conversations
- Establish stage-gate framework for pipeline investment decisions and criteria for advancing, partnering, or exiting assets
- Develop capital allocation logic across wholly owned, co-developed, and partnered programs
- Inform build vs. outsource vs. partner decisions for clinical development, CMC, and regulatory
- Support risk-balanced portfolio construction across indications, stages, and deal structures